Trials / Completed
CompletedNCT03051087
To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®
A Multicenter, Randomized, Treated-controlled, Parallel, Open Label Study to Compare and Evaluate the Efficacy and Safety of Ganilever PFS and Orgalutran® in Infertility Women for Assisted Reproductive Technologies
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 255 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- Female
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
to compare and evaluate the efficacy and safety of Ganilever PFS and Orgalutran® in infertility women for assisted reproductive technologies
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ganirelix acetate |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2017-02-13
- Last updated
- 2019-07-02
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03051087. Inclusion in this directory is not an endorsement.